107
Views
3
CrossRef citations to date
0
Altmetric
Original Research

NDC1 is a Prognostic Biomarker and Associated with Immune Infiltrates in Colon Cancer

, ORCID Icon, , & ORCID Icon
Pages 8811-8817 | Published online: 25 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Parisa Mohamadynejad, Mehdi Moghanibashi & Kambiz Bagheri. (2023) Identification of novel nuclear pore complex associated proteins in esophageal carcinoma by an integrated bioinformatics analysis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now

Articles from other publishers (2)

Qian Shen, Junchen Li, Chuanlong Zhang, Xue Pan, Yi Li, Xiyuan Zhang, Ge’er En & Bo Pang. (2023) Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer. Aging 15:18, pages 9779-9796.
Crossref
Xubin Li, Mengqiao Zhang, Xue Yu, Mei Xue, Xiaowei Li, Chao Ma, Wei Jia, Qiang Gao & Chunbo Kang. (2022) AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer. Journal of Oncology 2022, pages 1-13.
Crossref